Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
AUROLAB.BOthis companyAuro Laboratories Limited	₹228.35	47.87×	3.65×	5.5×	19.47×	-300.6%	80.3%	23.4%	11.5%	7.6%	4.7%	-7.7%	1.37×	5.22×	1.69×	1.08×	0.0%	4	—	2	C
AAREYDRUGS.NSAarey Drugs & Pharmaceuticals Limited	₹109.04	36.51×	0.96×	0.31×	14.58×	-99.9%	3.0%	0.9%	0.8%	2.6%	1.6%	-16.1%	0.33×	3.66×	0.86×	1.81×	0.0%	6	—	2	C
AUROPHARMA.NSAurobindo Pharma Limited	₹1,855.30	21.62×	2×	2.25×	10.17×	130.3%	39.2%	15.1%	10.4%	9.2%	7.3%	3.7%	0.21×	-0.25×	13.22×	1.81×	0.3%	5	—	2	B-
GODAVARI.BOGodavari Drugs Limited	₹121.00	15.84×	0.85×	0.61×	12.28×	-172.8%	19.1%	7.4%	3.9%	5.4%	4.1%	-46.3%	1.01×	6×	1.98×	1.31×	0.0%	2	—	2	C+
LASA.NSLasa Supergenerics Limited	₹4.22	-0.83×	0.57×	1.13×	-1.34×	-306.6%	-27.4%	-53.2%	-135.6%	-68.7%	-22.1%	0.0%	0.2×	-0.34×	-34.66×	0.62×	0.0%	2	—	2	C
MANGALAM.NSMangalam Drugs & Organics Limited	₹29.22	-0.97×	0.42×	0.19×	-9.91×	-175.0%	10.0%	-14.3%	-19.1%	-43.1%	-14.1%	-48.4%	1.02×	-7.03×	-2.04×	0.79×	0.0%	2	—	2	C
Peer median	—	15.84×	0.85×	0.61×	10.17×	-172.8%	10.0%	0.9%	0.8%	2.6%	1.6%	-16.1%	0.33×	-0.25×	0.86×	1.31×	0.0%	2	—	2	—